Literature DB >> 16398441

[Progress on the study of mechanism of the direct action of TCM bioactive components on ovarian cancer].

Fang Guo1, Cong-jian Xu.   

Abstract

Both the morbidity and mortality of ovarian cancer, among malignant tumors ot temale genital organs, are quite high. The traditional therapeutic methods on ovarian cancer are surgical operation, chemotherapy, radiotherapy and combination of these methods mentioned above. In recent years, some components of traditional Chinese medicine, such as genistein, semen Coicis, phytosterols, curcumin, quercetin, ginsenoside, etc. have been found to exert anticancer actions of inhibiting proliferation and inducing apoptosis of cancer cells, increasing the sensitivity of patients to chemotherapeutic agents in viva and/or in vitro, the mechanisms involve such aspects as inhibiting activity of key enzymes in cell metabolism, affecting gene expression, antioxidation, and inhibiting tumor angiogenesis, etc. As an adjuvant therapeutic means, the bioactive components of traditional Chinese medicine have broad future of clinical application.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16398441

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  3 in total

Review 1.  The Protective Effect of Dietary Phytosterols on Cancer Risk: A Systematic Meta-Analysis.

Authors:  Lu Jiang; Xin Zhao; Jun Xu; Chujun Li; Yue Yu; Wei Wang; Lingjun Zhu
Journal:  J Oncol       Date:  2019-06-23       Impact factor: 4.375

2.  Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.

Authors:  Muhammad Muzamil Khan; Asadullah Madni; Nayab Tahir; Farzana Parveen; Safiullah Khan; Nasrullah Jan; Ahsan Ali; Muhammad Abdurrahim; Umar Farooq; Muhammad Imran Khan
Journal:  Int J Nanomedicine       Date:  2020-03-30

Review 3.  Nanoformulations of curcumin: an emerging paradigm for improved remedial application.

Authors:  Meeta Gera; Neelesh Sharma; Mrinmoy Ghosh; Do Luong Huynh; Sung Jin Lee; Taesun Min; Taeho Kwon; Dong Kee Jeong
Journal:  Oncotarget       Date:  2017-07-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.